Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (291-300 of 632) with videos related to

Pageof 64
Sort By:
Hepatology (Baltimore, Md.)|August 5, 2010
High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trialUlrich F H Leuschner, Birgit Lindenthal, Günter Herrmann, et al.
Genetic Testing and Molecular Biomarkers|May 29, 2009
Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologiesJuliane Halangk, Thomas Berg, Konrad Neumann, et al.
Hepatology (Baltimore, Md.)|September 16, 2004
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis CHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Diagnostic Microbiology and Infectious Disease|May 15, 2010
Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysisJoerg Hofmann, Katrin Frenzel, Bui Q Minh, et al.
Journal of Hepatology|August 31, 2010
HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infectionChristian Markus Lange, Kirsten Roomp, Anette Dragan, et al.
The American Journal of Gastroenterology|June 22, 2007
Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinomaArne Scholz, Vanessa Annina Rehm, Svenja Rieke, et al.
The Lancet. Infectious Diseases|September 8, 2016
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)Vincent Mallet, Florian van Bömmel, Christopher Doerig, et al.
Zeitschrift Fur Gastroenterologie|June 27, 2018
[Prophylaxis, diagnosis and therapy of hepatitis-C-virus (HCV) infection: the German guidelines on the management of HCV infection - AWMF-Register-No.: 021/012]Christoph Sarrazin, Tim Zimmermann, Thomas Berg, et al.
JHEP Reports : Innovation in Hepatology|October 17, 2022
Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysisDana Sierks, Ria Schönauer, Anja Friedrich, et al.
Gut|September 28, 2017
Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriersMaria Pfefferkorn, Stephan Böhm, Tina Schott, et al.
Pageof 64

Showing results (291-300 of 632) with videos related to

Sort By:
Pageof 64
Hepatology (Baltimore, Md.)|August 5, 2010
High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trialUlrich F H Leuschner, Birgit Lindenthal, Günter Herrmann, et al.
Genetic Testing and Molecular Biomarkers|May 29, 2009
Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologiesJuliane Halangk, Thomas Berg, Konrad Neumann, et al.
Hepatology (Baltimore, Md.)|September 16, 2004
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis CHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Diagnostic Microbiology and Infectious Disease|May 15, 2010
Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysisJoerg Hofmann, Katrin Frenzel, Bui Q Minh, et al.
Journal of Hepatology|August 31, 2010
HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infectionChristian Markus Lange, Kirsten Roomp, Anette Dragan, et al.
The American Journal of Gastroenterology|June 22, 2007
Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinomaArne Scholz, Vanessa Annina Rehm, Svenja Rieke, et al.
The Lancet. Infectious Diseases|September 8, 2016
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)Vincent Mallet, Florian van Bömmel, Christopher Doerig, et al.
Zeitschrift Fur Gastroenterologie|June 27, 2018
[Prophylaxis, diagnosis and therapy of hepatitis-C-virus (HCV) infection: the German guidelines on the management of HCV infection - AWMF-Register-No.: 021/012]Christoph Sarrazin, Tim Zimmermann, Thomas Berg, et al.
JHEP Reports : Innovation in Hepatology|October 17, 2022
Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysisDana Sierks, Ria Schönauer, Anja Friedrich, et al.
Gut|September 28, 2017
Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriersMaria Pfefferkorn, Stephan Böhm, Tina Schott, et al.
Pageof 64